IXI MedTech - Clarity for Your MedTech Decisions
Medical Technology Background

Clarity for Your MedTech Decisions
in a Fog of Data

Our proprietary IXI intelligence engine transforms fragmented FDA clearance data into actionable signals, empowering you to see the next market shift before your competitors do.

Join the Invitation-Only Beta Program Now

Log in for immediate access or to join our exclusive waitlist. We are inviting forward-thinking leaders to co-create the future of MedTech intelligence.

In MedTech, a Detour Isn't Just a Delay. It's a Quantifiable Cost.

The MedTech industry runs on innovation, but it's plagued by an "information fog" that leads to costly detours. Our analysis of FDA 510(k) data reveals a stark 'experience moat':

~40 days

Faster market clearance for "expert-level" applicants vs. novices.

~80 days

The efficiency gap widens in the hyper-competitive AI device space.

Defining a New Altitude of Decision-Making for Every MedTech Leader

IXI MedTech delivers targeted intelligence to accelerate your specific commercial impact.

For MedTech Brands & Startups

  • Sharpen Your Edge: Gain critical insights into competitor dynamics to optimize your product's regulatory pathway.
  • Elevate Your Pitch: Present market opportunities in a data-driven manner to strengthen your fundraising narrative.

For Investors (VC & CVC)

  • Achieve Superior Returns: Leverage data-informed foresight to identify disruptive opportunities early and mitigate risks.
  • Deepen Due Diligence: Use our proprietary RFM analysis to precisely evaluate high-potential targets.

For CDMOs & Supply Chain

  • Anticipate Demand: Understand evolving product pipelines to strategically tailor your services and capabilities.
  • Acquire Strategically: Identify the most active innovators to build a robust pipeline of high-value clients.

IXI: The Cycle Where Insight Creates Impact

Our philosophy is an intelligent circulation engine that transforms data into decisions.

1

Signal Integration Across Lifecycles

We break down data silos—from Pre-Approval to Post-Approval—into a single, structured intelligence feed.

2

Proprietary RFM Analysis

We pioneered the application of the RFM model to FDA data, quantifying an applicant's innovation momentum and potential.

3

Actionable Intelligence Delivery

Our dashboards deliver clear, visual intelligence on "Consistent Leaders," "Growing Players," and "New Challengers."

IXI Cycle

See What's Possible: From Market Pulse to Competitive Deep-Dives

Our Beta Program provides exclusive access to our core intelligence modules, turning abstract data into concrete strategic assets.

510k Dashboard 功能示意圖

Instantly Grasp the Market Pulse

Our interactive 510(k) Dashboard provides a real-time snapshot of market dynamics. Did you know that over 27% of applicants in Q1 2025 were new entrants? We help you identify if they are future partners or emerging threats.

Deep-Dive into Competitive Landscapes

Go beyond simple lists. Use our RFM & Correlation Analysis to uncover the true competitive dynamics of key markets, from Bronchoscopes (EOQ) to AI Imaging Software (QIH), and identify players by their strategic posture.

Product Code R-F Dashboard 功能示意圖

Latest Insights & Analysis

Deep insights and industry analysis from our team.

Article image

October 22nd, 2025

NEWQ3 2025 FDA 510(k) Class II Analysis: New Entrants, Review Speed, and Emerging Product Codes in MedTech

Read More →
Article image

July 16th, 2025

Q2 2025 FDA Data Analysis: The Rise of AI Imaging Software & The Emerging Competitive Landscape

Read More →
Article image

May 21st, 2025

Harnessing FDA 510(k) Data Potential: RFM Modeling–A New Paradigm for MedTech Growth...

Read More →
Article image

May 14th, 2025

Who’s Leading the Pack? Who’s Catching Up? | 2025 Q1 FDA 510(k) Clearances

Read More →

Who We Are: A Deep Fusion of Industry Wisdom and Data Science

IXI MedTech is strategically co-created by two leading teams, combining decades of regulatory nuance with the power of scaled data analytics.

WISPRO

Brings nearly 20 years of hands-on industry experience, covering every critical decision point from "pre-approval" to "post-approval".

Mavus

Our key technology partner, injecting a rare DNA combining top-tier software engineering with a deep clinical medicine background.

WISPRO's industry wisdom defines "what questions to ask"; Mavus's data science provides "how to answer them at scale."

(For our full story, please visit our About Us page.)

Stop Navigating the Fog. Start Making Decisions with Clarity.

Your professional insights are the most valuable fuel for refining our product. Join us on a journey to co-create the future of decision-making in the medical device industry.